Form 4: Claritev Officer Granted 23,243 Restricted Stock Units

Sentiment:

Insider Transaction Disclosure


Claritev Corp's SVP and Chief Accounting Officer, Brock Albinson, was granted 23,243 restricted stock units, vesting annually over four years.

Summary

  • Brock Albinson, SVP and Chief Accounting Officer of Claritev Corp (CTEV), received a grant of 23,243 Class A common stock units.
  • The transaction occurred on March 1, 2026, with a reported price of $0 per unit, indicating a grant rather than a purchase.
  • These restricted stock units will vest at a rate of 25% per year on March 1, 2027, 2028, 2029, and 2030.
  • Following this transaction, Mr. Albinson beneficially owns 27,237 shares of Class A common stock.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive development, reflecting standard executive compensation practices designed to foster long-term alignment between management and shareholder interests, without indicating any immediate operational or financial changes.

Positives

  • The grant of restricted stock units aligns the interests of a key executive, Brock Albinson, with long-term shareholder value.
  • The vesting schedule encourages executive retention and sustained performance over a four-year period.

Negatives

  • No direct negatives are apparent from this specific Form 4 filing, which primarily reports an equity grant.

Future Outlook

The vesting schedule for the restricted stock units extends through March 1, 2030, indicating a long-term incentive structure for the SVP, Chief Accounting Officer.

Industry Context

StockSavvy.ai notes that equity grants, particularly restricted stock units with multi-year vesting schedules, are a standard practice in executive compensation across various industries. This practice aims to align executive incentives with long-term company performance and shareholder interests, common in technology and growth-oriented sectors where talent retention is crucial.

Related Party Transactions

  • The grant of restricted stock units to Brock Albinson, a Senior Vice President and Chief Accounting Officer, constitutes a transaction between the company and a key executive, which is a form of related party dealing in the context of executive compensation.

Stakeholder Impact

  • Shareholders: Potential positive impact due to increased alignment of executive incentives with long-term company performance.
  • Employees: May signal stability in executive leadership and a commitment to long-term growth.

Next Steps

  • 25% of the granted restricted stock units will vest on March 1, 2027.
  • Subsequent 25% portions will vest annually on March 1, 2028, 2029, and 2030.

Key Dates

DateDescription
03/01/2026Date of transaction: Grant of restricted stock units to Brock Albinson.
03/03/2026Date of Form 4 filing.
03/01/2027First vesting date for 25% of the restricted stock units.
03/01/2028Second vesting date for 25% of the restricted stock units.
03/01/2029Third vesting date for 25% of the restricted stock units.
03/01/2030Fourth and final vesting date for 25% of the restricted stock units.

Recommendation

hold

This Form 4 filing reports a routine equity grant to a senior executive, which is a standard component of executive compensation. While it aligns executive interests with long-term shareholder value, it does not provide new information that would fundamentally alter the investment thesis for Claritev Corp. Therefore, a 'hold' recommendation is appropriate as it doesn't present a strong catalyst for either buying or selling based solely on this disclosure.

Keywords

Claritev Corp, CTEV, Brock Albinson, Restricted Stock Units, RSU, Insider Transaction, Executive Compensation, Equity Grant, Form 4

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.